companydata.dkcompanydata.dk

FERTIN PHARMA A/S: Financial statements 2020

CVR: 25834844

Source: annual report 2020, Danish Business Authority

01/01/2020 – 31/12/2020

FERTIN PHARMA A/S (CVR 25834844) has filed annual accounts for 2020. In 2020, the company reported revenue of DKK 991,107,000 and a net result of DKK 155,411,000 compared with DKK 81,301,000 the year before. That is an increase of 12.4% compared with the year before. The profit margin was 15.7%. Equity in the 2020 report amounted to DKK 770,126,000. The solvency ratio was 38.5%. The company had 674 employees in the financial year.

Revenue
DKK 991,107,000
Gross Profit
DKK 246,394,000
Profit/Loss
DKK 155,411,000
Equity
DKK 770,126,000
Total Assets
DKK 1,998,384,000
Employees
674

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020991.1M246.4M155.4M770.1M674
2019881.6M190.8M81.3M778.3M661
2018812.5M121.4M45.8M896M609
2017867.7M208.5M106.4M770.5M572
2016855.7M546.5M100.1M659.6M530

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is FERTIN PHARMA A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

Peter Halling joins FERTIN PHARMA A/S as adm. dir.Aug 1, 2020

As of August 1, 2020, Peter Halling is registered as adm. dir. of FERTIN PHARMA A/S.

Søren Birn steps down as adm. dir. of FERTIN PHARMA A/SAug 1, 2020

As of August 1, 2020, Søren Birn has stepped down as adm. dir. of FERTIN PHARMA A/S.

FERTIN PHARMA A/S: The 2019 annual report is outApr 21, 2020

FERTIN PHARMA A/S has published its annual report for 2019. Revenue came to DKK 881,616,000, and the net result was DKK 81,301,000.

About FERTIN PHARMA A/S

FERTIN PHARMA A/S is a Danish company of the type Aktieselskab based in Vejle, founded in 2001. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The company was previously named JUT NR. 2128 A/S. The management consists of Michael Henrik Thomsen. The board consists of Christopher Beck Lambert (chair), Bo Korsgaard Jensen, Jovana Mejri and Michael Henrik Thomsen. The company is owned by Aspeya Inc.. The company has 959 employees (2026). In 2025, the company reported revenue of DKK 1,344,394,000 and a net result of DKK -280,841,000 compared with DKK -259,011,000 the year before. Equity in the 2025 report amounted to DKK 1,269,900,000.

Source: annual report 2025, Danish Business Authority